Literature DB >> 31735616

Scoring and Interpretation of the FSFI: What can be Learned From 20 Years of use?

Cindy M Meston1, Bridget K Freihart2, Ariel B Handy2, Chelsea D Kilimnik2, Raymond C Rosen3.   

Abstract

INTRODUCTION: Over the past 20 years, the Female Sexual Function Index (FSFI) has been considered the gold standard for the measurement of sexual function in women, with over 1,000 published manuscripts citing the article. Despite the measure's widespread usage and excellent psychometric properties, there has been some confusion over how to best implement and score the measure and interpret corresponding findings. AIM: The aim of the current article is to provide guidance, drawing from 20 years of use, on how to best implement the FSFI in research settings and interpret results based on the validation studies that have been conducted to date.
METHODS: The overview of scoring and interpretation procedures found in this article is drawn from a review of the published literature on the psychometric properties of the FSFI. MAIN OUTCOME MEASURE: The measure of interest for the present review is the FSFI.
RESULTS: This review article provides information about implementing, scoring, and interpreting the full-scale FSFI. Domain-level scoring and interpretation procedures are also discussed across the 5 domains of the FSFI: arousal, satisfaction, desire, pain, and lubrication. Additionally, guidance is provided for evaluating translated versions of the FSFI and using the measure to examine sexual function in culturally diverse populations. CLINICAL IMPLICATIONS: Guidance on appropriately scoring and interpretating the FSFI has the potential to strengthen our empirical understanding of sexual function, and consequently, to guide theory-driven treatment development and clinical practice. STRENGTH & LIMITATIONS: The present review provides applied guidance for the appropriate use of the FSFI specifically, but does not cover other common measures of sexual function or adaptations of the original measure.
CONCLUSION: It is our hope that the guidance found in this review will ultimately lead to more rigorous and appropriate usage of the FSFI in research settings. Meston CM, Freihart BK, Handy AB, et al. Scoring and Interpretation of the FSFI: What can be Learned From 20 Years of use? J Sex Med 2020;17:17-25.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Female Sexual Function Index (FSFI); Psychometric Review; Sexual Function

Year:  2019        PMID: 31735616     DOI: 10.1016/j.jsxm.2019.10.007

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  29 in total

1.  Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.

Authors:  Debra L Barton; Stephanie L Pugh; Patricia A Ganz; Steven C Plaxe; Bridget F Koontz; Jeanne Carter; Natalya Greyz-Yusupov; Seth J Page; Kendrith M Rowland; Ernie P Balcueva; Sobia Nabeel; Jack B Basil; Matthew L Hill; Carolyn Y Muller; Maria C Bell; Snehal Deshmukh; Lisa A Kachnic
Journal:  J Clin Oncol       Date:  2021-12-09       Impact factor: 44.544

2.  Sexual and Gender Minority Persons' Perception of the Female Sexual Function Index.

Authors:  Mia D Austria; Kathleen Lynch; Tiffany Le; Chasity Burrows Walters; Thomas M Atkinson; Andrew J Vickers; Sigrid V Carlsson
Journal:  J Sex Med       Date:  2021-10-31       Impact factor: 3.802

3.  Predictors of sexual function among men after myocardial infarction: a pilot study.

Authors:  Asa B Smith; Debra L Barton; Elizabeth A Jackson; Daniela Wittmann; Jacqui Smith; Matthew Davis
Journal:  Br J Card Nurs       Date:  2021-12-27

4.  Sexual history taking by doctors in primary care in North West province, South Africa: Patients at risk of sexual dysfunction overlooked.

Authors:  Deidre Pretorius; Ian D Couper; Motlatso G Mlambo
Journal:  Afr J Prim Health Care Fam Med       Date:  2022-05-23

5.  Internet Addiction and Polish Women's Sexual Functioning: The Role of Social Media, Online Pornography, and Game Use during the COVID-19 Pandemic-Online Surveys Based on FSFI and BSMAS Questionnaires.

Authors:  Anna Pawlikowska; Ewa Szuster; Paulina Kostrzewska; Amanda Mandera; Małgorzata Biernikiewicz; Małgorzata Sobieszczańska; Krystyna Rożek-Piechura; Monika Markiewicz; Agnieszka Rusiecka; Dariusz Kałka
Journal:  Int J Environ Res Public Health       Date:  2022-07-04       Impact factor: 4.614

6.  The Impact of Social Distancing Measures Due to COVID-19 Pandemic on Sexual Function and Relationship Quality of Couples in Greece.

Authors:  Paraskevi Sotiropoulou; Fotini Ferenidou; Dimitra Owens; Ioulia Kokka; Eirini Minopoulou; Evangelia Koumantanou; Iliana Pavlopoulou; Panagiotis Apotsos; Maria Karvouni; Elli Koumantarou; Iraklis Mourikis; Nikos Vaidakis; Charalambos Papageorgiou
Journal:  Sex Med       Date:  2021-05-26       Impact factor: 2.491

7.  Assessment of the Association of Cannabis on Female Sexual Function With the Female Sexual Function Index.

Authors:  Alex M Kasman; Hriday P Bhambhvani; Genester Wilson-King; Michael L Eisenberg
Journal:  Sex Med       Date:  2020-07-23       Impact factor: 2.491

8.  Couple Counseling and Pelvic Floor Muscle Training for Men Operated for Prostate Cancer and for Their Female Partners: Results From the Randomized ProCan Trial.

Authors:  Randi V Karlsen; Pernille E Bidstrup; Annamaria Giraldi; Helle Hvarness; Per Bagi; Susanne Vahr Lauridsen; Vanna Albieri; Marie Frederiksen; Eva Krause; Ulla Due; Christoffer Johansen
Journal:  Sex Med       Date:  2021-06-03       Impact factor: 2.491

9.  The Impact of COVID-19 on Female Sexual Health.

Authors:  Anna Fuchs; Aleksandra Matonóg; Joanna Pilarska; Paulina Sieradzka; Mateusz Szul; Bartosz Czuba; Agnieszka Drosdzol-Cop
Journal:  Int J Environ Res Public Health       Date:  2020-09-30       Impact factor: 3.390

10.  Overexpressing miR-122-5p Inhibits the Relaxation of Vaginal Smooth Muscle in Female Sexual Arousal Disorder by Targeting Vasoactive Intestinal Peptide Receptor 1.

Authors:  Shengnan Cong; Tao Gui; Qinchuan Shi; Jingjing Zhang; Jingyi Feng; Lianjun Pan; Jiehua Ma; Aixia Zhang
Journal:  Sex Med       Date:  2021-07-08       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.